[go: up one dir, main page]

EP1929031A4 - In-vitro-proteinsynthesesysteme für membranproteine mit apolipoproteinen und phospholipid-apolipoproteinpartikeln - Google Patents

In-vitro-proteinsynthesesysteme für membranproteine mit apolipoproteinen und phospholipid-apolipoproteinpartikeln

Info

Publication number
EP1929031A4
EP1929031A4 EP06825266A EP06825266A EP1929031A4 EP 1929031 A4 EP1929031 A4 EP 1929031A4 EP 06825266 A EP06825266 A EP 06825266A EP 06825266 A EP06825266 A EP 06825266A EP 1929031 A4 EP1929031 A4 EP 1929031A4
Authority
EP
European Patent Office
Prior art keywords
phospholipid
protein synthesis
membrane proteins
vitro protein
synthesis systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06825266A
Other languages
English (en)
French (fr)
Other versions
EP1929031A1 (de
Inventor
Wieslaw Kudlicki
Julia Fletcher
Federico Katzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of EP1929031A1 publication Critical patent/EP1929031A1/de
Publication of EP1929031A4 publication Critical patent/EP1929031A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP06825266A 2005-09-27 2006-09-27 In-vitro-proteinsynthesesysteme für membranproteine mit apolipoproteinen und phospholipid-apolipoproteinpartikeln Withdrawn EP1929031A4 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72133905P 2005-09-27 2005-09-27
US53596005A 2005-09-27 2005-09-27
US72421305P 2005-10-04 2005-10-04
US81575006P 2006-06-21 2006-06-21
US81569506P 2006-06-21 2006-06-21
PCT/US2006/038173 WO2007038755A1 (en) 2005-09-27 2006-09-27 In vitro protein synthesis systems for membrane proteins that include apolipoproteins and phospholipid-apolipoprotein particles

Publications (2)

Publication Number Publication Date
EP1929031A1 EP1929031A1 (de) 2008-06-11
EP1929031A4 true EP1929031A4 (de) 2012-01-11

Family

ID=37903589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06825266A Withdrawn EP1929031A4 (de) 2005-09-27 2006-09-27 In-vitro-proteinsynthesesysteme für membranproteine mit apolipoproteinen und phospholipid-apolipoproteinpartikeln

Country Status (3)

Country Link
EP (1) EP1929031A4 (de)
JP (1) JP2009521209A (de)
WO (1) WO2007038755A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090136937A1 (en) * 2007-05-09 2009-05-28 Coleman Matthew A Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
US8907061B2 (en) 2008-01-11 2014-12-09 Lawrence Livermore National Security, Llc. Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
US10151037B2 (en) 2009-01-12 2018-12-11 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide dependent target reduction, and related methods and systems
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
US12226529B2 (en) 2015-08-25 2025-02-18 Lawrence Livermore National Security, Llc Stable nanolipoprotein particles and related compositions methods and systems
WO2017044899A1 (en) 2015-09-11 2017-03-16 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
CA3001637A1 (fr) * 2015-10-16 2017-04-20 Universite Paris 7-Denis Diderot Procede de production de proteines erythrocytaires
WO2018204495A1 (en) 2017-05-02 2018-11-08 Synthetic Genomics, Inc. Nanolipoprotein particles and related compositions methods and systems for loading rna
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006039622A2 (en) * 2004-10-01 2006-04-13 Invitrogen Corporation Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
WO2008106660A2 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Isolated phospholipid-protein particles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1345959B1 (de) * 2000-11-20 2011-05-25 The Board Of Trustees Of The University Of Illinois Membrangerüstproteine
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
US7083958B2 (en) * 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006039622A2 (en) * 2004-10-01 2006-04-13 Invitrogen Corporation Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
WO2008106660A2 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Isolated phospholipid-protein particles

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CIVJAN N R ET AL: "Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers", BIOTECHNIQUES, INFORMA HEALTHCARE, US, vol. 35, no. 3, 1 September 2003 (2003-09-01), pages 556 - 563, XP001538917, ISSN: 0736-6205 *
KLAMMT C ET AL: "High level cell-free expression and specific labeling of integral membrane proteins", EUROPEAN JOURNAL OF BIOCHEMISTRY, BLACKWELL PUBLISHING, BERLIN, DE, vol. 271, no. 3, 1 January 2004 (2004-01-01), pages 568 - 580, XP008105291, ISSN: 0014-2956, [retrieved on 20040109], DOI: 10.1111/J.1432-1033.2003.03959.X *
See also references of WO2007038755A1 *

Also Published As

Publication number Publication date
EP1929031A1 (de) 2008-06-11
JP2009521209A (ja) 2009-06-04
WO2007038755A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
EG25848A (en) Systems and methods for protein production
EP2102355A4 (de) Proteine und peptide mit langer wirkung sowie verfahren zu ihrer herstellung und verwendung
IL181278A0 (en) Systems and methods for protein production
EP1859388A4 (de) Verfahren und systeme zur bildabtastung
EP1858546A4 (de) Modifizierte transferrinfusionsproteine
EG26619A (en) PEG-quadrangle arbor polymer for binding to proteins and peptides
IL190090A0 (en) Systems and methods for enrichment of analytes
PT2343320T (pt) Anticorpos anti-gitr e as suas utilizações
ZA200708332B (en) Antibodies against CCR5 and uses thereof
ZA200702634B (en) Prion protein binding materials and methods of use
EP1889908A4 (de) Mit anti-cd14-antikörper fusioniertes protein
IL191152A0 (en) Polypeptide films and methods
PL1923463T3 (pl) Peptyd antygenowy do odrzucania raka pochodzący z glipikan-3 (GPC3) do zastosowania u HLA-A2-pozytywnego pacjenta i środek farmaceutyczny zawierający antygen
GB0601102D0 (en) Kinase Peptides And Antibodies
EP1929031A4 (de) In-vitro-proteinsynthesesysteme für membranproteine mit apolipoproteinen und phospholipid-apolipoproteinpartikeln
PL1909602T3 (pl) Systemy i metody stosowane do oddzielania białek od tkanki łącznej
EP1848812A4 (de) Zufuhrpuffer, systeme und verfahren zur in-vitro-synthese von biomolekülen
IL189770A0 (en) In vitro assay for identification of allergenic proteins
GB0617197D0 (en) Hidden deck clip and hidden deck system
GB0516058D0 (en) New protein isoforms and uses thereof
EP2121726A4 (de) Proteinpartikel
EP1734983A4 (de) Modifizierte annexin-proteine und verfahren zur verhinderung von thrombose
EP1877425A4 (de) Fluoreszierende proteine und ihre verwendung
GB2446110B (en) Flow divider and separation system
EP1981704A4 (de) Vorrichtung und verfahren zur gewinnung von peptid- und proteinproben aus einer lösung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080311

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIFE TECHNOLOGIES CORPORATION

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20111212

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 1/00 20060101ALI20111206BHEP

Ipc: C12P 21/02 20060101AFI20111206BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120710